EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial

Reinoud E Knops iD, Jolien A de Veld iD, Abdul Ghani, Lucas V A Boersma iD, Juergen Kuschyk iD, Mikhael F El Chami iD, Hendrik Bonnemeier iD, Elijah R Behr iD, Tom F Brouwer iD, Stefan Kääb iD, Suneet Mittal iD, Shari Pepplinkhuizen iD und 36 weitere

Circulation: Cardiovascular Quality and Outcomes · 2024

DOI: 10.1161/circoutcomes.124.010822 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2024. Verfasst von Reinoud E Knops und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Amsterdam Cardiovascular Sciences Heart Failure and Arrhythmias, Amsterdam University Medical Centers Location University o…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Quality of Life, Electric Countershock, Mental Health. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome the risk of lead-related complications associated with the transvenous implantable cardioverter-defibrillator (TV-ICD). In contrast to the TV-ICD, the S-ICD is a completely extrathoracic device. Subsequently, complications differ between these 2 implantable cardioverter-defibrillators, which might impact patient perceptions of the therapies. This prespecified secondary analysis of the PRAETORIAN trial evaluates differences in quality of life. METHODS: The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) randomized patients with an implantable cardioverter-defibrillator indication, without the need for pacing to S-ICD or TV-ICD therapy. Two questionnaires were collected at baseline, discharge, 12 months, and 30 months. The Duke Activity Status Index measures cardiac-specific physical functioning, and the 36-Item Short Form Health Survey measures physical and mental well-being, with the subscales bodily pain and mental health being of interest in this analysis. Mann-Whitney U tests were used to compare study arms, and a mixed model was used to describe the questionnaire outcomes over time. RESULTS: Patients were randomized to S-ICD (n=426) and TV-ICD (n=423). In the S-ICD group, 20% were women versus 19% in the TV-ICD group. The median age was 63 (interquartile range, 54–69) years in the S-ICD group versus 64 (interquartile range, 56–69) years in the TV-ICD group. There were no significant differences in the Duke Activity Status Index and 36-Item Short Form Health Survey subscales for bodily pain and mental health between the groups at any time point. Patients with a shock in the last 90 days had significantly lower scores for social functioning ( P =0.008) and role limitations due to emotional problems ( P =0.001) than patients without a shock, but this effect did not differ between treatment arms. CONCLUSIONS: In a large randomized cohort of patients with an S-ICD or TV-ICD, no difference in overall quality of life was observed. However, implantable cardioverter-defibrillator shocks resulted in a reduction in quality of life, regardless of the device type or appropriateness. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01296022.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableQuality of LifeElectric CountershockMental HealthHumansFemaleMaleMiddle AgedAgedProspective StudiesTreatment OutcomeTime FactorsProsthesis DesignSurveys and QuestionnairesHealth StatusArrhythmias, CardiacFunctional StatusRisk FactorsDeath, Sudden, Cardiac

Stichwörter der Autor:innen

arrhythmias, cardiacdefibrillators, implantablemental healthquality of life

Autor:innen und Institutionen

  • Department of Cardiology, Amsterdam Cardiovascular Sciences Heart Failure and Arrhythmias, Amsterdam University Medical Centers Location University of Amsterdam, Heart Center, the Netherlands (R.E.K., J.A.d.V., L.V.A.B.…
  • Department of Cardiology, Isala Heart Centre, Zwolle, the Netherlands (A.G.).
  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands (L.V.A.B.).
  • First Department of Medicine, University Medical Center Mannheim, Germany (J.K.).
  • German Center for Cardiovascular Research, Partner Site Heidelberg, Mannheim, Germany (J.K.).
  • Division of Cardiology, Section of Electrophysiology, Emory University, Atlanta, GA (M.F.E.C.).

ORCID-Profile: Reinoud E Knops, Jolien A de Veld, Lucas V A Boersma, Juergen Kuschyk, Mikhael F El Chami, Hendrik Bonnemeier, Elijah R Behr, Tom F Brouwer, Stefan Kääb, Suneet Mittal, Shari Pepplinkhuizen, Anne-Floor B E Quast, Lonneke Smeding, Willeke van der Stuijt, Anouk de Weger, Nick R Bijsterveld, Sergio Richter, Joris R de Groot, Kirsten M Kooiman, Pier D Lambiase, Petr Neuzil, Kevin Vernooy, Marco Alings, Timothy R Betts, Frank A L E Bracke, Martin C Burke, Jonas S S G de Jong, David J Wright, Ward P J Jansen, Zachary I Whinnett, Peter Nordbeck, Michael Knaut, Berit T Philbert, Jurren M van Opstal, Alexandru B Chicos, Cornelis P Allaart, Alida E Borger van der Burg, Jose M Dizon, Ralf Surber, Gaurav A Upadhyay, Jan G P Tijssen, Arthur A M Wilde, Louise R A Olde Nordkamp

Zitieren

APA

Knops, R. E., de Veld, J. A., Ghani, A., Boersma, L. V. A., Kuschyk, J., El Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., Mittal, S., Pepplinkhuizen, S., Quast, A. B. E., Smeding, L., van der Stuijt, W., de Weger, A., Bijsterveld, N. R., Richter, S., Brouwer, M. A., …, & PRAETORIAN Investigators (2024). Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.124.010822

Vancouver

Knops RE, de Veld JA, Ghani A, Boersma LVA, Kuschyk J, El Chami MF, et al. Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circulation: Cardiovascular Quality and Outcomes. 2024. doi:10.1161/circoutcomes.124.010822

BibTeX
@article{Knops2024,
  author = {Knops, Reinoud E and de Veld, Jolien A and Ghani, Abdul and Boersma, Lucas V A and Kuschyk, Juergen and El Chami, Mikhael F and Bonnemeier, Hendrik and Behr, Elijah R and Brouwer, Tom F and Kääb, Stefan and Mittal, Suneet and Pepplinkhuizen, Shari and Quast, Anne-Floor B E and Smeding, Lonneke and van der Stuijt, Willeke and de Weger, Anouk and Bijsterveld, Nick R and Richter, Sergio and Brouwer, Marc A and de Groot, Joris R and Kooiman, Kirsten M and Lambiase, Pier D and Neuzil, Petr and Vernooy, Kevin and Alings, Marco and Betts, Timothy R and Bracke, Frank A L E and Burke, Martin C and de Jong, Jonas S S G and Wright, David J and Jansen, Ward P J and Whinnett, Zachary I and Nordbeck, Peter and Knaut, Michael and Philbert, Berit T and van Opstal, Jurren M and Chicos, Alexandru B and Allaart, Cornelis P and Borger van der Burg, Alida E and Dizon, Jose M and Miller, Marc A and Nemirovksy, Dmitry and Surber, Ralf and Upadhyay, Gaurav A and Tijssen, Jan G P and Wilde, Arthur A M and Olde Nordkamp, Louise R A and PRAETORIAN Investigators, PRAETORIAN Investigators},
  title = {Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial},
  journal = {Circulation: Cardiovascular Quality and Outcomes},
  year = {2024},
  doi = {10.1161/circoutcomes.124.010822}
}
Kostenlos starten →